Medical Condition News

RSS

Cyberonics enters agreement with NeuroVista for epilepsy technology development program

Cyberonics, Inc. today announced that it has entered into additional agreements with NeuroVista Corporation in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy.

25 Aug 2010

UT Southwestern University Hospital - St. Paul earns distinction as Primary Stroke Center

The Joint Commission has certified UT Southwestern University Hospital - St. Paul as a Primary Stroke Center, a distinction for hospitals fostering specialized stroke care for patients.

25 Aug 2010

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.

24 Aug 2010

Maria Shriver joins Alzheimer's Association to release The Shriver Report

Maria Shriver, in Partnership with the Alzheimer's Association, Takes a Groundbreaking Look into the Epidemic's Effect on Women as Caregivers, Advocates, and People Living With Alzheimer's.

24 Aug 2010

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.

24 Aug 2010

Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide Therapeutics

Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.

24 Aug 2010

Special empowerment program to promote confidence in diabetic children

Teens are learning how to shred down the mountain and balance blood sugars in a special empowerment program called Riding on Insulin, taking place December 11, 2010, at The Canyons Resort in Park City. The day, led by Sean Busby,26 year old professional snowboarder with type 1 diabetes promotes courage and confidence and shows children with type 1 or type 2 they can overcome mental and physical challenges.

24 Aug 2010

Abilities Expo to be held August 27-29, 2010 in Houston, Texas

Thousands of people with disabilities, their families, caregivers, seniors, veterans with disabilities and healthcare professionals are expected to attend Abilities Expo on Friday, August 27, through Sunday, August 29, 2010 at Reliant Center. Admission is free and show hours will be Friday 11 am to 5 pm, Saturday 10 am to 5 pm and Sunday 11 am to 4 pm.

24 Aug 2010

FRC applauds preliminary injunction to stop taxpayers for embryonic stem cell research

Family Research Council President Tony Perkins applauded today's preliminary injunction that for now stops taxpayer funded embryonic stem cell research. Judge Royce Lamberth noted that the imposition of an injunction required that those challenging the government's funding demonstrate a substantial likelihood of success on the merits for their arguments.

24 Aug 2010

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

24 Aug 2010

CVD prevention strategies for high-risk individuals may widen health inequalities

In a Policy Forum published this week in PLoS Medicine, Simon Capewell and Hilary Graham review different population strategies for preventing cardiovascular disease and conclude that screening and treating high-risk individuals may be ineffective and widen social inequalities. The authors conclude "there is evidence that CVD prevention strategies for screening and treating high-risk individuals may represent a relatively ineffective approach that typically widens social inequalities.

24 Aug 2010

MWellA online community promotes awareness on mental disorders

Mental health is a hot button issue in today's society. People worry about the safety, cost, and multiple side-effects of anti-depressants and other psychoactive medications. Everyone wants to find peace of mind, contentment and happiness, but for many this struggle can prove overwhelming. Author and world organic food movement pioneer Paul Huljich addresses this issue in a Ning community he created for his organization MWellA (Mind Wellness Awareness)

24 Aug 2010

Walter and Eliza Hall Institute researcher receives L'Oreal Fellowship for breast cancer research

A desire to understand how breast cancer starts has seen Walter and Eliza Hall Institute researcher Dr Marie-Liesse Asselin-Labat today win one of three 2010 L'Oreal Australia For Women in Science Fellowships.

24 Aug 2010

Deutsches Ärzteblatt International presents new PRISCUS List

In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[31-32]: 543-51), Stephanie Holt, a clinical pharmacologist, and coauthors present the PRISCUS List: a list of medications that carry an increased risk of side effects when given to elderly patients.

24 Aug 2010

Asian-Americans subgroups lack data on cardiovascular disease

Asians are the fastest-growing racial/ethnic group in the U.S., but data on cardiovascular disease is lacking. There are marked differences in heart disease risk and occurrence among Asian-American subgroups, but data on these subgroups is limited, prompting the American Heart Association to call for more research on this fastest-growing racial/ethnic group in the U.S., according to a scientific statement published in Circulation: Journal of the American Heart Association.

24 Aug 2010

Study finds multi-modal hemispheric based program improves participant's educational outcomes

A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes. The study, "The Effect of Hemispheric Specific Remediation Strategies on the Academic Performance Outcome of Children With ADD/ADHD," was conducted by a research team including, Gerry Leisman, Robert Melillo, Sharon Thum, Mark Ransom, Michael Orlando, Christopher Tice, and Frederick Carrick. The study appears in the current issue of the International Journal of Adolescent Medicine and Health.

24 Aug 2010

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago - but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.

24 Aug 2010

USPTO grants Taligen patent for TT30 lead product candidate

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled "Targeting Complement Factor H For Treatment of Diseases", covering the composition of matter for its lead product candidate, TT30, a novel fusion protein that selectively binds to complement activated cells to locally regulate the complement system.

24 Aug 2010

Gatherer Partnership to advance patient rehabilitation, conditioning techniques

New company to create objective analysis and measurement physiotherapy products to improve support for critical decisions relating to patient assessment, condition and the need for surgical intervention.

24 Aug 2010

PEM scanners demonstrate improved specificity with high sensitivity in breast cancer diagnosis: Study

In a recent study presented at the American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting, researchers at the University of Washington showed that 18FDG dose for Positron Emission Mammography (PEM) may be reduced by as much as 70% without altering image quality.

24 Aug 2010

Medical Condition News

Cyberonics enters agreement with NeuroVista for epilepsy technology development program

UT Southwestern University Hospital - St. Paul earns distinction as Primary Stroke Center

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

Maria Shriver joins Alzheimer's Association to release The Shriver Report

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide Therapeutics

Special empowerment program to promote confidence in diabetic children

Abilities Expo to be held August 27-29, 2010 in Houston, Texas

FRC applauds preliminary injunction to stop taxpayers for embryonic stem cell research

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

CVD prevention strategies for high-risk individuals may widen health inequalities

MWellA online community promotes awareness on mental disorders

Walter and Eliza Hall Institute researcher receives L'Oreal Fellowship for breast cancer research

Deutsches Ärzteblatt International presents new PRISCUS List

Asian-Americans subgroups lack data on cardiovascular disease

Study finds multi-modal hemispheric based program improves participant's educational outcomes

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

USPTO grants Taligen patent for TT30 lead product candidate

Gatherer Partnership to advance patient rehabilitation, conditioning techniques

PEM scanners demonstrate improved specificity with high sensitivity in breast cancer diagnosis: Study

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News